Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Marissa Mock, Alex W. Jacobitz, Christopher James Langmead, Athena Sudom, Daniel Yoo, Sara C. Humphreys, Mai Alday, Larysa Alekseychyk, Nicolas Angell, Vivian Bi, Hannah Catterall, Chen-Chun Chen, Hui-Ting Chou, Kip P. Conner, Kevin D. Cook, Ana R. Correia, Andrew Dykstra, Sudipa Ghimire-Rijal, Kevin Graham, Peter Grandsard, Joon Huh, John O. Hui, Mani Jain, Victoria Jann, Lei Jia, Sheree Johnstone, Neelam Khanal, Carl Kolvenbach, Linda Narhi, Rupa Padaki, Emma M. Pelegri-O’Day, Wei Qi, Vladimir Razinkov, Austin J. Rice, Richard Smith, Christopher Spahr, Jennitte Stevens, Yax Sun, Veena A. Thomas, Sarah van Driesche, Robert Vernon, Victoria Wagner, Kenneth W. Walker, Yangjie Wei, Dwight Winters, Melissa Yang & Iain D. G. Campuzano. (2023) Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies. mAbs 15:1.
Read now
Read now
Catherine Y Liu, Cory L Ahonen, Michael E Brown, Ling Zhou, Martin Welin, Eric M Krauland, Robert Pejchal, Paul F Widboom & Michael B Battles. (2023) Structure-based engineering of a novel CD3ε-targeting antibody for reduced polyreactivity. mAbs 15:1.
Read now
Read now
Andrew Dippel, Austin Gallegos, Vineela Aleti, Arnita Barnes, Xiaoru Chen, Elizabeth Christian, Jared Delmar, Qun Du, Reza Esfandiary, Erika Farmer, Andrew Garcia, Qing Li, Jia Lin, Weiyi Liu, LeeAnn Machiesky, Neil Mody, Arun Parupudi, Meagan Prophet, Keith Rickert, Kim Rosenthal, Song Ren, Harini Shandilya, Reena Varkey, Kevin Wons, Yuling Wu, Yueh-Ming Loo, Mark T. Esser, Nicole L. Kallewaard, Sarav Rajan, Melissa Damschroder, Weichen Xu & Gilad Kaplan. (2023) Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies. mAbs 15:1.
Read now
Read now
David Falck, Martin Lechmann, Ana Momčilović, Marco Thomann, Carolien A. M. Koeleman, Cordula Jany, Sebastian Malik, Manfred Wuhrer & Dietmar Reusch. (2022) Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model. mAbs 14:1.
Read now
Read now
Shihao Hu, Amita Datta-Mannan & David Z. D’Argenio. (2022) Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties. mAbs 14:1.
Read now
Read now
Orla Cunningham, Martin Scott, Zhaohui Sunny Zhou & William J.J. Finlay. (2021) Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns. mAbs 13:1.
Read now
Read now
Boris Grinshpun, Nels Thorsteinson, Joao NS Pereira, Friedrich Rippmann, David Nannemann, Vanita D. Sood & Yves Fomekong Nanfack. (2021) Identifying biophysical assays and in silico properties that enrich for slow clearance in clinical-stage therapeutic antibodies. mAbs 13:1.
Read now
Read now
Emily K. Makowski, Lina Wu, Priyanka Gupta & Peter M. Tessier. (2021) Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. mAbs 13:1.
Read now
Read now
Lise I. Loberg, Meha Chhaya, Alexander Ibraghimov, Edit Tarcsa, Andreas Striebinger, Andreas Popp, Lili Huang, Frank Oellien & Stefan Barghorn. (2021) Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeys. mAbs 13:1.
Read now
Read now
David Falck, Marco Thomann, Martin Lechmann, Carolien A. M. Koeleman, Sebastian Malik, Cordula Jany, Manfred Wuhrer & Dietmar Reusch. (2021) Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody. mAbs 13:1.
Read now
Read now
Amita Datta-Mannan, Selina Estwick, Chen Zhou, Hiuwan Choi, Nicole E. Douglass, Derrick R. Witcher, Jirong Lu, Catherine Beidler & Rohn Millican. (2020) Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies. mAbs 12:1.
Read now
Read now
Thomas E. Kraft, Wolfgang F. Richter, Thomas Emrich, Alexander Knaupp, Michaela Schuster, Andreas Wolfert & Hubert Kettenberger. (2020) Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis. mAbs 12:1.
Read now
Read now
Lindsay B. Avery, Jason Wade, Mengmeng Wang, Amy Tam, Amy King, Nicole Piche-Nicholas, Mania S. Kavosi, Steve Penn, David Cirelli, Jeffrey C. Kurz, Minlei Zhang, Orla Cunningham, Rhys Jones, Brian J. Fennell, Barry McDonnell, Paul Sakorafas, James Apgar, William J. Finlay, Laura Lin, Laird Bloom & Denise M. O'Hara. (2018) Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics. mAbs 10:2, pages 244-255.
Read now
Read now
Ryan L. Kelly, Jessie Zhao, Doris Le & K. Dane Wittrup. (2017) Nonspecificity in a nonimmune human scFv repertoire. mAbs 9:7, pages 1029-1035.
Read now
Read now
Miro J. Eigenmann, Ludivine Fronton, Hans Peter Grimm, Michael B. Otteneder & Ben-Fillippo Krippendorff. (2017) Quantification of IgG monoclonal antibody clearance in tissues. mAbs 9:6, pages 1007-1015.
Read now
Read now
Claudia A. Castro Jaramillo, Sara Belli, Anne-Christine Cascais, Sherri Dudal, Martin R. Edelmann, Markus Haak, Marie-Elise Brun, Michael B. Otteneder, Mohammed Ullah, Christoph Funk, Franz Schuler & Silke Simon. (2017) Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms. mAbs 9:5, pages 781-791.
Read now
Read now
Ryan L. Kelly, Yao Yu, Tingwan Sun, Isabelle Caffry, Heather Lynaugh, Michael Brown, Tushar Jain, Yingda Xu & K. Dane Wittrup. (2016) Target-independent variable region mediated effects on antibody clearance can be FcRn independent. mAbs 8:7, pages 1269-1275.
Read now
Read now
Articles from other publishers (42)
Emily K. Makowski, Tiexin Wang, Jennifer M. Zupancic, Jie Huang, Lina Wu, John S. Schardt, Anne S. De Groot, Stephanie L. Elkins, William D. Martin & Peter M. Tessier. (2023) Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning. Nature Biomedical Engineering.
Crossref
Crossref
Ahizechukwu C. Eke, Rahel D. Gebreyohannes, Maria Fernanda Scantamburlo Fernandes & Venkateswaran C. Pillai. (2023) Physiologic Changes During Pregnancy and Impact on Small‐Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response. The Journal of Clinical Pharmacology 63:S1.
Crossref
Crossref
V. V. Smirnov, O. A. Petukhova, A. V. Filatov, D. A. Kudlay & M. R. Khaitov. (2023) Studying the pharmacokinetics of biotechnological medicinal products on the example of monoclonal antibodies. Biological Products. Prevention, Diagnosis, Treatment 23:2, pages 173-180.
Crossref
Crossref
Andreas Evers, Shipra Malhotra, Wolf-Guido Bolick, Ahmad Najafian, Maria Borisovska, Shira Warszawski, Yves Fomekong Nanfack, Daniel Kuhn, Friedrich Rippmann, Alejandro Crespo & Vanita Sood. 2023. Genotype Phenotype Coupling. Genotype Phenotype Coupling
383
398
.
Martin R. Edelmann. (2022) Radiolabelling small and biomolecules for tracking and monitoring. RSC Advances 12:50, pages 32383-32400.
Crossref
Crossref
Rohit Sharma, Shishu K. Suman & Archana Mukherjee. (2022) Antibody-based Radiopharmaceuticals as Theranostic Agents: An
Overview. Current Medicinal Chemistry 29:38, pages 5979-6005.
Crossref
Crossref
Ahmet Alptekin, Mahrima Parvin, Hasanul I. Chowdhury, Mohammad H. Rashid & Ali S. Arbab. (2022) Engineered exosomes for studies in tumor immunology. Immunological Reviews 312:1, pages 76-102.
Crossref
Crossref
Emily K. Makowski, Patrick C. Kinnunen, Jie Huang, Lina Wu, Matthew D. Smith, Tiexin Wang, Alec A. Desai, Craig N. Streu, Yulei Zhang, Jennifer M. Zupancic, John S. Schardt, Jennifer J. Linderman & Peter M. Tessier. (2022) Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space. Nature Communications 13:1.
Crossref
Crossref
Mohamed Sharafeldin & Jason J. Davis. (2022) Characterising the biosensing interface. Analytica Chimica Acta 1216, pages 339759.
Crossref
Crossref
Priyanka Gupta, Emily K. Makowski, Sandeep Kumar, Yulei Zhang, Justin M. Scheer & Peter M. Tessier. (2022) Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties. Molecular Pharmaceutics 19:3, pages 775-787.
Crossref
Crossref
Deni Hardiansyah & Chee Meng Ng. (2022) Minimal Physiologically-based Pharmacokinetic Model to Investigate the Effect of Charge on the Pharmacokinetics of Humanized anti-HCV-E2 IgG Antibodies in Sprague–Dawley Rats. Pharmaceutical Research 39:3, pages 481-496.
Crossref
Crossref
Robert S. Foti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
716
742
.
Lucky Ahmed, Priyanka Gupta, Kyle P. Martin, Justin M. Scheer, Andrew E. Nixon & Sandeep Kumar. (2021) Intrinsic physicochemical profile of marketed antibody-based biotherapeutics. Proceedings of the National Academy of Sciences 118:37.
Crossref
Crossref
Gabor Jarvas, Dora Szerenyi, Jozsef Tovari, Laszlo Takacs & Andras Guttman. (2021) Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy. Molecules 26:16, pages 4845.
Crossref
Crossref
John Hood, Ignacio González-García, Nicholas White, Leeron Marshall, Vincent F. S. Dubois, Paolo Vicini & Paul G. Baverel. (2021) Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total. Pharmaceutics 13:4, pages 519.
Crossref
Crossref
Vittal Shivva, Martin Fink & Philip J. Lowe. (2021) Improving priors for human monoclonal antibody linear pharmacokinetic parameters by using half-lives from non-human primates. Journal of Pharmacokinetics and Pharmacodynamics 48:2, pages 295-303.
Crossref
Crossref
Alec A. Desai, Matthew D. Smith, Yulei Zhang, Emily K. Makowski, Julia E. Gerson, Edward Ionescu, Charles G. Starr, Jennifer M. Zupancic, Shannon J. Moore, Alexandra B. Sutter, Magdalena I. Ivanova, Geoffrey G. Murphy, Henry L. Paulson & Peter M. Tessier. (2021) Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity. Journal of Biological Chemistry 296, pages 100508.
Crossref
Crossref
Sofia Rossini, Rémi Noé, Victoria Daventure, Maxime Lecerf, Sune Justesen & Jordan D. Dimitrov. (2020) V Region of IgG Controls the Molecular Properties of the Binding Site for Neonatal Fc Receptor. The Journal of Immunology 205:10, pages 2850-2860.
Crossref
Crossref
Christopher T Boughter, Marta T Borowska, Jenna J Guthmiller, Albert Bendelac, Patrick C Wilson, Benoit Roux & Erin J Adams. (2020) Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops. eLife 9.
Crossref
Crossref
John S. Ruano-Salguero & Kelvin H. Lee. (2020) Adsorptive-Mediated Endocytosis of Sulfo-Cy5-Labeled IgG Causes Aberrant IgG Processing by Brain Endothelial-Like Cells. Molecular Pharmaceutics 17:11, pages 4280-4285.
Crossref
Crossref
Esther Kuilamu, Christopher Subasic, Gary J Cowin, Fiona Simpson, Rodney F Minchin & Lisa M Kaminskas. (2020) Cetuximab Exhibits Sex Differences in Lymphatic Exposure after Intravenous Administration in Rats in the Absence of Differences in Plasma Exposure. Pharmaceutical Research 37:11.
Crossref
Crossref
Yulei Zhang, Lina Wu, Priyanka Gupta, Alec A. Desai, Matthew D. Smith, Lilia A. Rabia, Seth D. Ludwig & Peter M. Tessier. (2020) Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity. Molecular Pharmaceutics 17:7, pages 2555-2569.
Crossref
Crossref
Antoine Petitcollin, Amina Bensalem, Marie-Clémence Verdier, Camille Tron, Florian Lemaitre, Gilles Paintaud, Eric Bellissant & David Ternant. (2019) Modelling of the Time-Varying Pharmacokinetics of Therapeutic Monoclonal Antibodies: A Literature Review. Clinical Pharmacokinetics 59:1, pages 37-49.
Crossref
Crossref
Mark L. Chiu, Dennis R. Goulet, Alexey Teplyakov & Gary L. Gilliland. (2019) Antibody Structure and Function: The Basis for Engineering Therapeutics. Antibodies 8:4, pages 55.
Crossref
Crossref
Charles G Starr & Peter M Tessier. (2019) Selecting and engineering monoclonal antibodies with drug-like specificity. Current Opinion in Biotechnology 60, pages 119-127.
Crossref
Crossref
Robert S. Foti, Kaustav Biswas, Jennifer Aral, Xuhai Be, Loren Berry, Yuan Cheng, Kip Conner, James R. Falsey, Charles Glaus, Brad Herberich, Dean Hickman, Tayo Ikotun, Hongyan Li, Jason Long, Liyue Huang, Les P. Miranda, Justin Murray, Bryan Moyer, Chawita Netirojjanakul, Thomas E. Nixey, Kelvin Sham, Marcus Soto, Christopher M. Tegley, Linh Tran, Bin Wu, Lin Yin & Dan A. Rock. (2019) Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species. Drug Metabolism and Disposition 47:10, pages 1111-1121.
Crossref
Crossref
Amita Datta-Mannan. (2019) Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides. Drug Metabolism and Disposition 47:10, pages 1100-1110.
Crossref
Crossref
Kenneth W. Walker, Hossein Salimi-Moosavi, Gregory E. Arnold, Qing Chen, Marcus Soto, Frederick W. Jacobsen & John Hui. (2019) Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates. PLOS ONE 14:5, pages e0217061.
Crossref
Crossref
Jung-Eun Kim, Keunok Jung, Jeong-Ah Kim, Seung-Hyun Kim, Hae-Sim Park & Yong-Sung Kim. (2019) Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity. Scientific Reports 9:1.
Crossref
Crossref
Mark C. Julian, Lilia A. Rabia, Alec A. Desai, Ammar Arsiwala, Julia E. Gerson, Henry L. Paulson, Ravi S. Kane & Peter M. Tessier. (2019) Nature-inspired design and evolution of anti-amyloid antibodies. Journal of Biological Chemistry 294:21, pages 8438-8451.
Crossref
Crossref
Kenta Haraya, Tatsuhiko Tachibana & Tomoyuki Igawa. (2019) Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering. Drug Metabolism and Pharmacokinetics 34:1, pages 25-41.
Crossref
Crossref
Dennis R. Goulet, Michael J. Watson, Susan H. Tam, Adam Zwolak, Mark L. Chiu, William M. Atkins & Abhinav Nath. (2018) Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance. Drug Metabolism and Disposition 46:12, pages 1900-1907.
Crossref
Crossref
Lilia A Rabia, Yulei Zhang, Seth D Ludwig, Mark C Julian & Peter M Tessier. (2018) Net charge of antibody complementarity-determining regions is a key predictor of specificity. Protein Engineering, Design and Selection 31:11, pages 409-418.
Crossref
Crossref
Lilia A. Rabia, Alec A. Desai, Harkamal S. Jhajj & Peter M. Tessier. (2018) Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility. Biochemical Engineering Journal 137, pages 365-374.
Crossref
Crossref
Paul J. Carter & Greg A. Lazar. (2017) Next generation antibody drugs: pursuit of the 'high-hanging fruit'. Nature Reviews Drug Discovery 17:3, pages 197-223.
Crossref
Crossref
Ryan L. Kelly, Doris Le, Jessie Zhao & K. Dane Wittrup. (2018) Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries. Journal of Molecular Biology 430:1, pages 119-130.
Crossref
Crossref
Meike Hutt, Lisa Marquardt, Oliver Seifert, Martin Siegemund, Ines Müller, Dagmar Kulms, Klaus Pfizenmaier & Roland E. Kontermann. (2017) Superior Properties of Fc-comprising scTRAIL Fusion Proteins. Molecular Cancer Therapeutics 16:12, pages 2792-2802.
Crossref
Crossref
Mei Han, Josh T. Pearson, Yunan Wang, Dwight Winters, Marcus Soto, Dan A. Rock & Brooke M. Rock. (2017) Immunoaffinity capture coupled with capillary electrophoresis - mass spectrometry to study therapeutic protein stability in vivo. Analytical Biochemistry 539, pages 118-126.
Crossref
Crossref
Martin Klinger. (2017) A role for macromolecular crowding in off-target binding of therapeutic antibodies. Protein Engineering, Design and Selection 30:7, pages 489-494.
Crossref
Crossref
Tushar JainTingwan SunStéphanie DurandAmy HallNga Rewa HoustonJuergen H. Nett, Beth Sharkey, Beata Bobrowicz, Isabelle CaffryYao YuYuan CaoHeather LynaughMichael BrownHemanta BaruahLaura T. GrayEric M. KraulandYingda XuMaximiliano VásquezK. Dane Wittrup. (2017) Biophysical properties of the clinical-stage antibody landscape. Proceedings of the National Academy of Sciences 114:5, pages 944-949.
Crossref
Crossref
Paul J. Smith & Pratip K. Chattopadhyay. (2016) Re-visiting Fc-receptor blocking maneuvers in man. Cytometry Part A 89:11, pages 975-977.
Crossref
Crossref
João Pedro Martins, Patrick J. Kennedy, Hélder A. Santos, Cristina Barrias & Bruno Sarmento. (2016) A comprehensive review of the neonatal Fc receptor and its application in drug delivery. Pharmacology & Therapeutics 161, pages 22-39.
Crossref
Crossref